Clinical Development Expertise Aids IQVIA (IQV), Costs High
IQVIA(IQV) ZACKS·2024-07-01 21:05
IQVIA Holdings Inc. (IQV) gains on a significantly large addressable market and innovations in its offerings. However, investors might not find the stock attractive given that it does not pay cash dividends and might not pay in the future.IQV has reported impressive first-quarter 2024 results. Adjusted earnings (excluding 98 cents from non-recurring items) were $2.5 per share, which beat the Zacks Consensus Estimate by 2.8% and increased 3.7% from the year-ago reported figure. Total revenues of $3.7 billion ...